Clinical Trial Update: Study of RADPLAT and Tarceva in Locally Advanced Head and Neck Squamous Cell Carcinoma (SCCA) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating the combination of RADPLAT (radiation with intra-arterial cisplatin) and Tarceva (erlotinib) for locally advanced head …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• Tarceva (erlotinib)

Snippet

Sponsor: Southern Illinois University | Conditions: Head and Neck Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-07-27